Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Home

Header Top Menu

  • News & Featured Stories
  • Media
  • Careers
  • Contact Us
  • Our Science

    Sub Menu 1

    • Pfizer in the UK
      • Our History
      • Pharmaceutical Sciences
      • Devices Centre of Excellence
      • Global Regulatory Affairs
      • Material Characterisation Team
      • Anti-Counterfeit Laboratory
    • Our Therapy Areas
      • Anti-Infectives
      • Inflammation and Immunology
      • Internal Medicine
      • Oncology
      • Rare Disease
      • Vaccines

    Sub Menu 2

    • Developing New Medicines
      • Clinical Trials
      • Pipeline
    • Research partnerships
      • ADDoPT
      • Innovative Target Exploration Network (ITEN)
      • INSPIRE Programme
      • Medical Research Council Collaboration
      • The Stratified Medicine Programme
      • Partnership with Regeneron for UK Biobank exome sequencing
    • Breakthroughs that change patients’ lives
    Hot Topic

    Re-shaping Cancer

    Re-shaping cancer
  • Products

    Sub Menu 4

    • Prescription medicines

    Sub Menu 5

    • Safety of Medicines
      • Medicines Regulation
      • Reporting Side Effects
      • Counterfeit Medicines
    Hot Topic

    Vaccines partnerships

    Vaccines partnerships
  • Responsibility

    Sub Menu 7

    • Transparency
      • HCP & HCO Annual Disclosure Reports
      • Healthcare Organisation Grants
      • Research and Development Funding
      • Patient Organisation Funding and Support
    • Codes of Conduct
      • Gender Pay Gap Report
      • Section 172 Statements
      • Pfizer UK Modern Slavery Statement
      • Pfizer UK Tax Strategy

    Sub Menu 8

    • Environmental Sustainability
      • Climate Action
      • Global Actions
      • Our Partnerships & Commitments
      • Sustainable Medicines
      • UK Actions
    • Insurance Details
    • Animal Welfare
    Hot Topic

    Putting Patients First

    Putting Patients First
  • UK Society

    Sub Menu 10

    • Social Investment
      • Volunteering and Fundraising
      • Medicines Donations
    • Raising Public Awareness
      • Change the Course
      • Pfizer Sponsors Science Museum Group's 'Cancer Revolution' Exhibition
      • Pfizer Sponsors the Superhero Series
      • Pfizer sponsors Science Museum exhibition 'Superbugs'
      • Pfizer at the British Science Festival
      • Turning Heads at Westminster

    Sub Menu 11

    • Science Education
      • Developing Science Talent
      • 'Superbugs Join The Fight' School Programme
      • Online Learning
        • Student Education Area
        • Teacher Resources
      • Community Lab
      • Career Talks
      • Lab in a Box
    • Pfizer Worldwide
      • Global Health Fellows
      • Global Aid and Emergency Relief
      • International Trachoma Initiative
    Hot Topic

    'Superbugs' Competition Winners

    Superbugs Winners
  • UK Health System

    Sub Menu 16

    • Working with the NHS and other Healthcare Organisations
      • Collaborative Working
        • Collaborative Working Project between Lloyds Pharmacy and Pfizer Vaccines
        • Joint Working
      • Donations and Grants
        • Independent Medical Grants and Donations
        • Donations of Goods, Services and Benefit in Kind
        • Grants
        • Donations and Grants Enquiry Form
    • Working with Healthcare Professionals
      • FAQs: Working with Healthcare Professionals
      • Pharmacy
      • Healthcare Professionals Congress Sponsorship

    Sub Menu 17

    • Working with Patient Organisations
      • Patient Involvement in Research and Development
      • Our ongoing partnership with the UK Sepsis Trust
      • Partnering with the NIHR and young people on clinical research
    • Pfizer Healthcare Hub
      • Pfizer Healthcare Hub: 2018
      • Pfizer Healthcare Hub: 2017
      • Connect with the Hub
    Hot topic

    Osteoarthritis

    Osteoarthritis
  • News & Featured Stories
  • Media
  • Careers

    Carrers

    • Search Current Vacancies
    • Apprenticeships
      • Apprenticeship Vacancies
    • Undergraduate Placements
      • Undergraduate Vacancies
    • Meet our people
    • UK Top Employer
  • Contact Us
  • Footer links

    Footer mobile menu

    • Footer Menu
    • Footer menu
      • Contact Us
      • Cookie Policy
      • Terms of Use
      • Privacy Policy
      • Sitemap
    • Footer social item
      • Facebook
      • Twitter
      • Instagram
      • YouTube

Our Humanitarian Response to the Ukraine conflict

Our Humanitarian Response to the Ukraine conflict
News & Featured Stories/ Our Humanitarian Response to the Ukraine conflict
04/03/2022

Last updated: 6th April 2022

Pfizer stands with all who are suffering as a result of the conflict in Ukraine. 

 

We are committed to ensuring the safety of our colleagues and their families and facilitating continued access to our medicines for patients. While we are closely monitoring the situation, we are also taking action:



The Pfizer Foundation

Through The Pfizer Foundation*, we have provided $2 million USD in humanitarian grant funding to three organisations working in the Ukraine and neighbouring countries:

  • American Red Cross to support emergency teams now in Ukraine and working to repair vital infrastructure, support health facilities with medicines and equipment, and support families with food and hygiene items. Funds donated through American Red Cross will support the Ukrainian Red Cross response as well as regional Red Cross efforts in surrounding countries to support immediate needs of affected populations
  • International Medical Corps to support essential emergency and primary health services, as well as mental health and psychosocial support services, and protection and gender-based violence services, which are critical for conflict-affected communities. COVID-19 awareness and prevention services will be incorporated to help keep displaced people safe from the pandemic.
  • International Rescue Committee to support their efforts in bordering countries to mobilise resources and connect with partners to establish a response that will provide life-saving support to civilians forced to flee their homes.
  • The UN Refugee Agency to support emergency relief priorities in Ukraine and immediate needs of displaced populations in surrounding countries now hosting Ukraine refugees. UNHCR is the leading UN agency coordinating all inter-agency regional efforts across UN agencies, NGOs and other relevant partners to maximize and effectively coordinate refugee response efforts.

 

Ukraine Humanitarian Disaster Campaign

Additionally, we have launched the 'Ukraine Humanitarian Disaster Campaign' to provide all Pfizer colleagues the opportunity to donate to key organisations. The Pfizer Foundation will be proudly matching donations made through the campaign to UNICEF, Save the Children International, International Rescue Committee, the American Red Cross, CARE, Nova Ukraine, and Sunflower of Peace.

  • As of March 11, 2022, thousands of colleagues from around the world have donated nearly US $621,000
  • Including The Pfizer Foundation’s dollar-for-dollar match, the total donation is approaching US $1.25million

 

Medicine Donations

Through our partnership with International Health Partners (IHP) we have donated medicines which will go to refugees coming from the Ukraine into surrounding countries (Moldova and Poland). Pfizer is also donating essential medicines through Direct Relief to support patients in Ukraine and bordering countries.

 

Company Position in Russia

The international community has implemented unprecedented sanctions to Russia however, for humanitarian reasons, medicines were excluded from these sanctions. Pfizer concluded that a voluntary pause in the flow of our medicines to Russia, including cancer or cardiovascular therapies, would cause significant patient suffering and potential loss of life, particularly among children and elderly people.

However, maintaining the supply of medicines to Russia does not mean we will continue doing business as usual in Russia. In March, Pfizer announced that it will donate all profits of its Russian subsidiary to causes that provide direct humanitarian support to the people of Ukraine. This is in addition to the humanitarian donations listed above. 

Additionally, we will no longer initiate new clinical trials in Russia, and we will stop recruiting new patients in our ongoing clinical trials in the country. Pfizer will work with the U.S. Food and Drugs Administration (FDA) and other regulators to transition all ongoing clinical trials to alternative sites outside Russia. Consistent with our commitment to putting patients first, we will continue providing needed medicines to the patients already enrolled in clinical trials.

Finally, while Pfizer doesn’t own or operate any manufacturing sites in Russia, we will cease all planned investments with local suppliers intended to build manufacturing capacity in the country.

These decisions align with our patient-first values and ensure that every dollar of profit derived from Russia will strengthen Ukraine and its people as they continue to valiantly defend their nation and freedom from this unprovoked and unjustified attack.

 

We join with the international community in expressing sincere hope for a swift resolution. The path towards equity must include peace.


*The Pfizer Foundation is a charitable organisation established by Pfizer Inc. It is a separate legal entity from Pfizer Inc. with distinct legal restrictions.

PP-UNP-GBR-0524 / April 2022

Related Hot Topics
How Pfizer is Fighting Climate Change
Carbon Neutral by 2030: How Pfizer is Fighting Climate Change with Ambitious…
Superbugs Winners
Pfizer UK announces ‘Superbugs: Join the Fight’ Competition winners
Duchenne Dash
Duchenne Dash Fundraiser - Why a team of Pfizer colleagues are cycling '…
Sandwich Economic Report
Sandwich Economic Impact Report Launched
Tags
UK Society

Footer

  • Contact Us
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Sitemap

Footer aside

  • Footer Aside
    • Facebook
    • Twitter
    • Instagram
    • YouTube

Copyright © 2017-2022 Pfizer Limited. PP-PFE-GBR-4248 / Nov 2021. All rights reserved. Registered in England and Wales No. 526209. Registered office: Ramsgate Road, Sandwich, Kent CT13 9NJ. VAT No. GB201048427